Publicaciones en colaboración con investigadores/as de University of Miami (21)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection

    Transplant Infectious Disease, Vol. 25, Núm. 2

2021

  1. Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study

    Clinical Infectious Diseases, Vol. 73, Núm. 4, pp. E955-E966

  2. Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2709-2718

2020

  1. Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

    Frontiers in Pediatrics, Vol. 8

2018

  1. Preclinical Studies of Stem Cell Therapy for Heart Disease

    Circulation Research, Vol. 122, Núm. 7, pp. 1006-1020

2017

  1. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

    World Journal of Emergency Surgery

2016

  1. Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    World Journal of Emergency Surgery, Vol. 11, Núm. 1

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

2014

  1. Update on transcobalamin deficiency: Clinical presentation, treatment and outcome

    Journal of Inherited Metabolic Disease, Vol. 37, Núm. 3, pp. 461-473

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

2008

  1. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738

  2. Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings

    Transplantation, Vol. 86, Núm. 5, pp. 647-651

  3. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

    Clinical Infectious Diseases, Vol. 46, Núm. 2

2007

  1. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality

    Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764

2005

  1. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome

    Transplantation, Vol. 80, Núm. 8, pp. 1131-1133

  2. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

    Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761

  3. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection

    Transplantation, Vol. 80, Núm. 8, pp. 1033-1039

  4. Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)

    Journal of Cardiac Failure, Vol. 11, Núm. 4, pp. 260-269

2001

  1. Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies

    AIDS, Vol. 15, Núm. 3, pp. 357-368